Dr. Broder recalled one instance in which it took him a day to understand the intricacies of a genetic disease. After tests in Brazil by Oxitec, the British biotech company owned by Intrexon, showed a fall of 82% in the population of wild mosquitoes after the introduction of its genetically engineered mosquitoes whose offspring die before reaching adulthood, the FDA is "greatly expediting" the company's application for further testing in the Florida Keys and is planning to release a draft environmental assessment soon. The FDA's decision comes as scientists are increasingly concerned about the impact that genetically modified organisms (GMOs) may have on human health.
After tests in Brazil by Oxitec, the British biotech company owned by Intrexon, showed a fall of 82% in the population of wild mosquitoes after the introduction of its genetically engineered mosquitoes whose offspring die before reaching adulthood, the FDA is "greatly expediting" the company's application for further testing in the Florida Keys and is planning to release a draft environmental assessment soon. The FDA's decision comes as scientists are increasingly concerned about the impact that genetically modified organisms (GMOs) may have on human health.